The ongoing and completed clinical trials involving representative natural compounds (e.g., curcumin, resveratrol, and related phytochemicals), including their clinical indications, trial phases, and key outcomes
The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
B12 & Autoimmune Disorders
You just converted an active pharmaceutical ingredient into an expensive clear liquid with no therapeutic value